Showing results (2801-2810 of 4,129) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|October 3, 2008
Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growthChunping Qiao, Juan Li, Hui Zheng, et al.Human Gene Therapy|October 3, 2008
Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in miceWilliam M Siders, Jacqueline Shields, Johanne Kaplan, et al.Human Gene Therapy|October 17, 2007
Modification of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-deficient monocytesGillian L McNab, Ali Ahmad, Dippica Mistry, et al.Human Gene Therapy|October 20, 2007
Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virusKuo-Shiang Huang, Wen-Hsin Lo, Yao-Chi Chung, et al.Human Gene Therapy|October 3, 2007
Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectorsMichio Nakai, Kazuo Komiya, Masashi Murata, et al.Human Gene Therapy|October 4, 2007
Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector doseVolker M Betz, Oliver B Betz, Vaida Glatt, et al.Human Gene Therapy|November 21, 2007
Hydrodynamics- and ultrasound-based transfection of heart with naked plasmid DNALeonardo Pinto de Carvalho, Daniela Takeshita, Bruno A Carillo, et al.Human Gene Therapy|November 26, 2008
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytesPeter M Rabinovich, Marina E Komarovskaya, Stephen H Wrzesinski, et al.Human Gene Therapy|June 7, 2007
Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) miceFu Xiong, Shaobo Xiao, Funing Peng, et al.Human Gene Therapy|June 28, 2007
A model for optimizing adenoviral delivery in human cancer gene therapy trialsKenneth N Barton, Svend O Freytag, Teamour Nurushev, et al.Pageof 413